NO20063231L - Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer - Google Patents

Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer

Info

Publication number: NO20063231L
Authority: NO; Norway
Prior art keywords: pde; pyrido; diamines; pyrimidine; inhibitors
Prior art date: 2003-12-16

Application number

NO20063231A

Other languages

English (en)

Norwegian (no)

Inventor

Andrew Ian Morrell

David Duane Thompson

Robert James Chambers

Thomas Arthur Beyer

Kelvin Lam

Mel Li

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-16

Filing date

2006-07-11

Publication date

2006-07-11

2006-07-11 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-07-11 Publication of NO20063231L publication Critical patent/NO20063231L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

NO20063231A 2003-12-16 2006-07-11 Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer NO20063231L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US52999403P	2003-12-16	2003-12-16
PCT/IB2004/004013 WO2005061497A1 (en)	2003-12-16	2004-12-06	Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors

Publications (1)

Publication Number	Publication Date
NO20063231L true NO20063231L (no)	2006-07-11

Family

ID=34710150

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063231A NO20063231L (no)	2003-12-16	2006-07-11	Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer

Country Status (39)

Country	Link
US (1)	US20070135457A1 (zh)
EP (1)	EP1697356B1 (zh)
JP (1)	JP4073944B2 (zh)
KR (1)	KR100816179B1 (zh)
CN (1)	CN100439366C (zh)
AP (1)	AP2006003632A0 (zh)
AR (1)	AR046766A1 (zh)
AT (1)	ATE387446T1 (zh)
AU (1)	AU2004303609A1 (zh)
BR (1)	BRPI0417663A (zh)
CA (1)	CA2549510A1 (zh)
CL (1)	CL2008001920A1 (zh)
DE (1)	DE602004012154T2 (zh)
DK (1)	DK1697356T3 (zh)
EA (1)	EA010424B1 (zh)
EC (1)	ECSP066643A (zh)
ES (1)	ES2299888T3 (zh)
GE (1)	GEP20094720B (zh)
GT (1)	GT200400268A (zh)
HN (1)	HN2004000538A (zh)
HR (1)	HRP20080142T3 (zh)
IL (1)	IL175813A0 (zh)
IS (1)	IS8474A (zh)
MA (1)	MA28270A1 (zh)
MX (1)	MXPA06006777A (zh)
NL (1)	NL1027787C2 (zh)
NO (1)	NO20063231L (zh)
PE (1)	PE20050681A1 (zh)
PL (1)	PL1697356T3 (zh)
PT (1)	PT1697356E (zh)
RS (1)	RS50575B (zh)
SI (1)	SI1697356T1 (zh)
SV (1)	SV2005001979A (zh)
TN (1)	TNSN06186A1 (zh)
TW (1)	TWI291961B (zh)
UA (1)	UA83091C2 (zh)
UY (1)	UY28671A1 (zh)
WO (1)	WO2005061497A1 (zh)
ZA (1)	ZA200604970B (zh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1960372B1 (en) *	2005-12-15	2015-12-09	Rigel Pharmaceuticals, Inc.	Kinase inhibitors and their uses
CN101573127B (zh) *	2006-09-21	2013-04-10	大黑俊树	硬组织再生促进剂
JP5472638B2 (ja) *	2008-03-18	2014-04-16	日産化学工業株式会社	１−（置換フェニル）−１−置換シリルエーテル、アルコールまたはケトンの製造方法および中間体
US20120065165A1 (en) *	2008-10-31	2012-03-15	Arginetix, Inc	Compositions and methods of treating endothelial disorders
EP2456440B1 (en)	2009-07-22	2015-08-19	Merck Sharp & Dohme Corp.	Quinolinone pde2 inhibitors
US8440710B2 (en)	2009-10-15	2013-05-14	Hoffmann-La Roche Inc.	HSL inhibitors useful in the treatment of diabetes
US9540379B2 (en)	2011-01-31	2017-01-10	Boehringer Ingelheim International Gmbh	(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
EA201391558A1 (ru)	2011-04-20	2014-05-30	Глэксо Груп Лимитед	Тетрагидропиразоло[1,5-а]пиримидины как противотуберкулезные соединения
PE20142258A1 (es)	2012-04-25	2015-01-15	Takeda Pharmaceutical	Compuesto heterociclico nitrogenado
JP6205356B2 (ja)	2012-07-13	2017-09-27	武田薬品工業株式会社	複素環化合物
US20140045856A1 (en)	2012-07-31	2014-02-13	Boehringer Ingelheim International Gmbh	4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
EP2975031A4 (en)	2013-03-14	2017-04-19	Takeda Pharmaceutical Company Limited	Heterocyclic compound
WO2015002231A1 (ja)	2013-07-03	2015-01-08	武田薬品工業株式会社	複素環化合物
US10472376B2 (en)	2013-07-03	2019-11-12	Takeda Pharmaceutical Company Limited	Amide compound
WO2015012328A1 (ja) *	2013-07-24	2015-01-29	武田薬品工業株式会社	複素環化合物
EP3087060B1 (en)	2013-12-23	2020-05-13	Merck Sharp & Dohme Corp.	Pyrimidone carboxamide compounds as pde2 inhibitors
JP6696904B2 (ja)	2014-01-08	2020-05-20	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	製剤および医薬組成物
MX2017000713A (es) *	2014-08-01	2017-05-01	Firmenich & Cie	Dispersion solida de compuestos con sabor de amida.
JP6608934B2 (ja)	2014-12-06	2019-11-20	イントラ−セルラー・セラピーズ・インコーポレイテッド	有機化合物
JP6608933B2 (ja)	2014-12-06	2019-11-20	イントラ−セルラー・セラピーズ・インコーポレイテッド	有機化合物
WO2016145614A1 (en)	2015-03-17	2016-09-22	Merck Sharp & Dohme Corp.	Triazolyl pyrimidinone compounds as pde2 inhibitors
US10287269B2 (en)	2015-03-26	2019-05-14	Merck Sharp & Dohme Corp.	Pyrazolyl pyrimidinone compounds as PDE2 inhibitors
WO2016179059A1 (en)	2015-05-05	2016-11-10	Merck Sharp & Dohme Corp.	Heteroaryl-pyrimidinone compounds as pde2 inhibitors
WO2016183741A1 (en)	2015-05-15	2016-11-24	Merck Sharp & Dohme Corp.	Pyrimidinone amide compounds as pde2 inhibitors
WO2016191935A1 (en)	2015-05-29	2016-12-08	Merck Sharp & Dohme Corp.	6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors
WO2016192083A1 (en) *	2015-06-04	2016-12-08	Merck Sharp & Dohme Corp.	Dihydropyrazolopyrimidinone compounds as pde2 inhibitors
WO2016209749A1 (en)	2015-06-25	2016-12-29	Merck Sharp & Dohme Corp.	Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors
WO2017000277A1 (en) *	2015-07-01	2017-01-05	Merck Sharp & Dohme Corp.	Substituted triazolo bicycliccompounds as pde2 inhibitors
WO2017000276A1 (en)	2015-07-01	2017-01-05	Merck Sharp & Dohme Corp.	Bicyclic heterocyclic compounds as pde2 inhibitors
EP3156405A1 (en)	2015-10-13	2017-04-19	Boehringer Ingelheim International GmbH	Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxamide
GB201700814D0 (en) *	2017-01-17	2017-03-01	Liverpool School Tropical Medicine	Compounds
EP3713572A1 (en)	2017-11-23	2020-09-30	Oslo University Hospital HF	Treatment of tachycardia
CN109758458B (zh) *	2019-03-05	2021-02-23	中国人民解放军陆军军医大学第二附属医院	抑制Crif1与PKA相互作用的化合物的应用
WO2022187411A1 (en) *	2021-03-02	2022-09-09	Kumquat Biosciences Inc.	Heterocycles and uses thereof
AU2023255692A1 (en)	2022-04-20	2024-10-03	Kumquat Biosciences Inc.	Macrocyclic heterocycles and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2749344A (en) *	1953-01-02	1956-06-05	Burroughs Wellcome Co	Pyrimidine compounds
US3021332A (en) *	1954-01-04	1962-02-13	Burroughs Wellcome Co	Pyrido (2, 3-d) pyrimidine compounds and method of making
US2926166A (en) *	1954-01-04	1960-02-23	Burroughs Wellcome Co	Pyrido (2, 3-d) pyrimidine compounds and method of making
US2924599A (en) *	1956-07-16	1960-02-09	Anchor Chemical Company Ltd	Derivatives of 1:3:5-triazanaphthalene
US2937284A (en) *	1958-05-01	1960-05-17	Burroughs Wellcome Co	2, 4-diamino-5, 6-dialkylpyrido (2, 3-d) pyrimidines and method
US3288792A (en) *	1962-07-05	1966-11-29	Burroughs Wellcome Co	Method of preparing 2, 4-diamino-6-alkylpyrido (2, 3-d) pyrimidines
DE3422824A1 (de) *	1984-06-20	1986-01-02	Celamerck Gmbh & Co Kg, 6507 Ingelheim	Neue herbizid wirksame sulfonylharnstoffe
US6194166B1 (en) *	1993-05-24	2001-02-27	Takara Shuzo Co., Ltd.	Gene regulating aureobasidin sensitivity
US5547954A (en) *	1994-05-26	1996-08-20	Fmc Corporation	2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
US6262059B1 (en) *	1995-06-07	2001-07-17	Cell Pathways, Inc.	Method of treating a patient having precancerous lesions with quinazoline derivatives
US6184226B1 (en) *	1998-08-28	2001-02-06	Scios Inc.	Quinazoline derivatives as inhibitors of P-38 α
PE20030008A1 (es) *	2001-06-19	2003-01-22	Bristol Myers Squibb Co	Inhibidores duales de pde 7 y pde 4

2004
- 2004-12-06 CA CA002549510A patent/CA2549510A1/en not_active Abandoned
- 2004-12-06 ES ES04801323T patent/ES2299888T3/es active Active
- 2004-12-06 AT AT04801323T patent/ATE387446T1/de not_active IP Right Cessation
- 2004-12-06 AU AU2004303609A patent/AU2004303609A1/en not_active Abandoned
- 2004-12-06 KR KR1020067011800A patent/KR100816179B1/ko not_active IP Right Cessation
- 2004-12-06 BR BRPI0417663-4A patent/BRPI0417663A/pt not_active IP Right Cessation
- 2004-12-06 PT PT04801323T patent/PT1697356E/pt unknown
- 2004-12-06 JP JP2006544574A patent/JP4073944B2/ja not_active Expired - Fee Related
- 2004-12-06 CN CNB2004800376743A patent/CN100439366C/zh not_active Expired - Fee Related
- 2004-12-06 WO PCT/IB2004/004013 patent/WO2005061497A1/en active Application Filing
- 2004-12-06 AP AP2006003632A patent/AP2006003632A0/xx unknown
- 2004-12-06 EP EP04801323A patent/EP1697356B1/en active Active
- 2004-12-06 GE GEAP20049461A patent/GEP20094720B/en unknown
- 2004-12-06 DK DK04801323T patent/DK1697356T3/da active
- 2004-12-06 EA EA200600973A patent/EA010424B1/ru not_active IP Right Cessation
- 2004-12-06 DE DE602004012154T patent/DE602004012154T2/de not_active Expired - Fee Related
- 2004-12-06 RS RSP-2008/0172A patent/RS50575B/sr unknown
- 2004-12-06 PL PL04801323T patent/PL1697356T3/pl unknown
- 2004-12-06 SI SI200430637T patent/SI1697356T1/sl unknown
- 2004-12-06 UA UAA200606683A patent/UA83091C2/ru unknown
- 2004-12-06 MX MXPA06006777A patent/MXPA06006777A/es active IP Right Grant
- 2004-12-06 US US10/595,766 patent/US20070135457A1/en not_active Abandoned
- 2004-12-15 AR ARP040104668A patent/AR046766A1/es not_active Application Discontinuation
- 2004-12-15 TW TW093138972A patent/TWI291961B/zh active
- 2004-12-15 NL NL1027787A patent/NL1027787C2/nl not_active IP Right Cessation
- 2004-12-15 UY UY28671A patent/UY28671A1/es not_active Application Discontinuation
- 2004-12-15 GT GT200400268A patent/GT200400268A/es unknown
- 2004-12-16 SV SV2004001979A patent/SV2005001979A/es not_active Application Discontinuation
- 2004-12-16 HN HN2004000538A patent/HN2004000538A/es unknown
2005
- 2005-01-03 PE PE2005000028A patent/PE20050681A1/es not_active Application Discontinuation
2006
- 2006-05-18 IS IS8474A patent/IS8474A/is unknown
- 2006-05-22 IL IL175813A patent/IL175813A0/en unknown
- 2006-06-15 ZA ZA200604970A patent/ZA200604970B/en unknown
- 2006-06-15 EC EC2006006643A patent/ECSP066643A/es unknown
- 2006-06-16 MA MA29113A patent/MA28270A1/fr unknown
- 2006-06-16 TN TNP2006000186A patent/TNSN06186A1/fr unknown
- 2006-07-11 NO NO20063231A patent/NO20063231L/no not_active Application Discontinuation
2008
- 2008-03-28 HR HR20080142T patent/HRP20080142T3/xx unknown
- 2008-06-27 CL CL200801920A patent/CL2008001920A1/es unknown

Also Published As

Publication number	Publication date
PE20050681A1 (es)	2005-10-04
JP4073944B2 (ja)	2008-04-09
TW200522952A (en)	2005-07-16
SI1697356T1 (sl)	2008-06-30
US20070135457A1 (en)	2007-06-14
ES2299888T3 (es)	2008-06-01
MA28270A1 (fr)	2006-11-01
WO2005061497A1 (en)	2005-07-07
TWI291961B (en)	2008-01-01
RS50575B (sr)	2010-05-07
NL1027787A1 (nl)	2005-06-21
HRP20080142T3 (en)	2008-06-30
NL1027787C2 (nl)	2006-03-09
GT200400268A (es)	2005-09-20
IL175813A0 (en)	2006-10-05
AP2006003632A0 (en)	2006-06-30
CN100439366C (zh)	2008-12-03
DK1697356T3 (da)	2009-01-12
KR20060105776A (ko)	2006-10-11
TNSN06186A1 (fr)	2007-11-15
CA2549510A1 (en)	2005-07-07
DE602004012154D1 (de)	2008-04-10
KR100816179B1 (ko)	2008-03-28
HN2004000538A (es)	2008-02-21
PL1697356T3 (pl)	2008-07-31
UY28671A1 (es)	2005-07-29
UA83091C2 (en)	2008-06-10
DE602004012154T2 (de)	2009-03-12
ATE387446T1 (de)	2008-03-15
CN1894245A (zh)	2007-01-10
BRPI0417663A (pt)	2007-04-03
AR046766A1 (es)	2005-12-21
ECSP066643A (es)	2006-10-25
PT1697356E (pt)	2008-05-05
EP1697356A1 (en)	2006-09-06
JP2007513996A (ja)	2007-05-31
MXPA06006777A (es)	2006-08-23
GEP20094720B (en)	2009-06-25
AU2004303609A1 (en)	2005-07-07
EA010424B1 (ru)	2008-08-29
EA200600973A1 (ru)	2006-10-27
ZA200604970B (en)	2007-11-28
SV2005001979A (es)	2005-12-13
IS8474A (is)	2006-05-18
CL2008001920A1 (es)	2008-10-17
EP1697356B1 (en)	2008-02-27

Publication	Publication Date	Title
NO20063231L (no)	2006-07-11	Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
SE0202463D0 (sv)	2002-08-14	Novel compounds
NO20035210D0 (no)	2003-11-24	2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer
NO20061839L (no)	2006-06-26	Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
WO2005051301A3 (en)	2006-05-18	Heterocyclic inhibitors of mek and methods of use thereof
NO20062591L (no)	2006-09-20	Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
NO20060147L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
MX2007009372A (es)	2007-09-21	Nuevos compuestos ii derivados de 2-piridina como inhibidores de elastasa neutrofila.
NO20083250L (no)	2008-09-22	Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
NO20060146L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
AP1564A (en)	2006-02-02	Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
HK1105977A1 (en)	2008-02-29	Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation
AU2003250471A1 (en)	2004-02-25	Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
SE0300908D0 (sv)	2003-03-31	Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
RS53211B (en)	2014-08-29	PYRIDO [2,3-d] PYRIMIDINE DERIVATIVES, THEIR PRODUCTION, THEIR USE IN THERAPY
NO20052182L (no)	2005-05-03	Nye forbindelser
NO20090332L (no)	2009-03-12	4-amino-3-arylamino-6-arylpyrazol[3,4-D]pyrimidinderivater, fremgangsmater for deres fremstilling og dere anvendelse som antivirale midler
GB0308201D0 (en)	2003-05-14	Novel compounds
SE0202461D0 (sv)	2002-08-14	Novel compounds
WO2006110173A3 (en)	2006-11-23	Novel compounds
HK1105978A1 (en)	2008-02-29	Pyrrolo [3,2-c]pyridine derivatives and processes for the preparation thereof
NO20055515L (no)	2006-01-24	7-azaindoler og deres anvendelse som terapeutiske midler
WO2004106329A3 (en)	2005-01-13	Novel antiinfective compounds and their pharmaceutical compositions
NO20054289D0 (no)	2005-09-16	Imiciazo[4,5-b]kinolinderivater og dem anvendelse som NO-syntaseinhibitorer
PL1603907T3 (pl)	2007-03-30	Podstawione pirydo[1,2-a]pirymidyny i ich zastosowanie jako inhibitorów-NOS

Legal Events

Date	Code	Title	Description
2010-07-19	FC2A	Withdrawal, rejection or dismissal of laid open patent application